Subscribe free

HPB & Spleen ·

Increased Mortality in Robotic Pancreatic Surgery

Surgeons need to be aware that robotic pancreaticoduodenectomy (RPD) initially carries higher mortality risks compared to open procedures.

  • 30-day mortality for RPD is 2.7%, compared to 2.0% for open pancreaticoduodenectomy (adjusted relative risk 1.43, p = 0.029).
  • Mortality risk significantly decreases with surgeon experience: 0.92% for those with 19-71 RPD cases (Q5) versus 3.9% for less experienced surgeons (Q1).

Structured training programs are crucial for safely adopting robotic techniques to improve patient outcomes.

Journal Article by Donnelly CB, Sacks GD (…) Massie AB et 4 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →